Magnetic properties of Ho2Fe17-xMnx - Influence of Mn substitution
The structural and magnetic properties of Ho2Fe17−xMnx (x=0−5) have been investigated by x-ray diffraction, Mossbauer spectroscopy and DC magnetization measurements (0-5 T) over the temperature range 4.5–350 K. Similar to other ferrimagnetic R2Fe17−xMnx systems, the unit cell volume generally increases with Mn content other than for low Mn values where a slight maximum is detected around x ~ 0.5. The nature of the magnetic phase transitions around TC is shown by Arrot plot analysis to be second order for all samples. The Curie temperature remains essentially unchanged for Mn contents up to x=1.0 (TC = 336 K for x=0.0, TC = 338 K for x=1.0) before decreasing steadily with further increase in Mn content (TC = 209 K for x=5). The 57Fe hyperfine interaction parameters have been determined from variable temperature Mossbauer spectra.
Effect of Mn substitution on the volume and magnetic properties of Er2Fe17
The effects of Mn substitution on the magnetic properties of Er2Fe17−xMnx compounds have been investigated by different experimental techniques. An unusual composition dependence of the unit cell volume at room temperature occurs due to a strong magnetovolume effect, which has been confirmed by high temperature linear thermal expansion measurements. From magnetization measurements the composition dependence of the spontaneous magnetization of the 3d-sublattice magnetic moment and of the Curie temperature has been determined. Spin reorientation has been detected for compounds with 3⩽x⩽5.5, as well as remarkable magnetic history effects.
An injectable and thermosensitive hydrogel: Promoting periodontal regeneration by controlled-release of aspirin and erythropoietin.
Periodontitis is an inflammatory disease induced by complex interactions between host immune system and plaque microorganism. Alveolar bone resorption caused by periodontitis is considered to be one of the main reasons for tooth loss in adults. To terminate the alveolar bone resorption, simultaneous anti-inflammation and periodontium regeneration is required, which has not appeared in the existing methods. In this study, chitosan (CS), β-sodium glycerophosphate (β-GP), and gelatin were used to prepare an injectable and thermosensitive hydrogel, which could continuously release aspirin and erythropoietin (EPO) to exert pharmacological effects of anti-inflammation and tissue regeneration, respectively. The releasing profile showed that aspirin and EPO could be continuously released from the hydrogels, which exhibited no toxicity both in vitro and in vivo, for at least 21 days. Immunohistochemistry staining and micro-CT analyses indicated that administration of CS/β-GP/gelatin hydrogels loaded with aspirin/EPO could terminate the inflammation and recover the height of the alveolar bone, which is further confirmed by histological observations. Our results suggested that CS/β-GP/gelatin hydrogels are easily prepared as drug-loading vectors with excellent biocompatibility, and the CS/β-GP/gelatin hydrogels loaded with aspirin/EPO are quite effective in anti-inflammation and periodontium regeneration, which provides a great potential candidate for periodontitis treatment in the dental clinic. Statement of Significance To terminate the alveolar bone resorption caused by periodontitis, simultaneous anti-inflammation and periodontium regeneration is required, which has not appeared in the existing methods. Here, (1) the chitosan (CS)/β-sodium glycerophosphate/gelatin hydrogels loaded with aspirin/erythropoietin (EPO) can form at body temperature in 5 min with excellent biocompatibility in vitro and in vivo; (2) The faster release of aspirin than EPO in the early stage is beneficial for anti-inflammation and provides a microenvironment for ensuring the regeneration function of EPO in the following step. In vivo experiments revealed that the hydrogels are effective in the control of inflammation and regeneration of the periodontium. These results indicate that our synthesized hydrogels have a great potential in the future clinical application.